Psoriasis trials in Japan
5 of 7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Chuo-ku, Fukuoka, Meguro-ku, Meguro-Ku, Minami-ku, Nagoya-shi, Mitaka-shi, Nagoya, Osaka, Sasebo-Shi, Sendai, Tsu, Mie
- Age
- 18 years and over
- People
- 1,182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Fuchū, Kanazawa, Kobe, Kumamoto, Matsumoto, Saga, Yokohama
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Asahikawa-shi, Chūōku, Fukuoka, Gifu, Kanazawa, Kurume, Fukuoka, Nagoya-sh, Okayama, Ōtsu, Sakaishi, Suita, Suita-shi, tabashi City, Toyoake Shi
- Age
- 40 years and over
- People
- 3,040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - Phase 3Taking peopleA Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Fukuoka, Jonan-Ku, Isehara, Nagoya, Osaka, Shinjuku-ku, tabashi City, Tsu
- Age
- 4 years to 18 years
- People
- 153 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00 - Phase 3Taking peopleA Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
- Where
- Kitakyushu-shi, Nagoya, Osaka, tabashi City, Tsu, Mie
- Age
- 4 years to 17 years
- People
- 110 worldwide
- Run by
- Takeda
See details and how to joinNCT07250802 · EU 2025-522567-15-00